SC134-TCB targeting fucosyl-GM1, a T cell engaging antibody with potent anti-tumour activity in preclinical small-cell lung cancer models
Article in Molecular Cancer Therapeutics (August 2024)
The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.
Article in Molecular Cancer Therapeutics (August 2024)
Article in International Immunopharmacology (July 2024)
Article in Acta Pharmacologica Sinica (June 2024)